Advertisement

Dermatoethics pp 237-240 | Cite as

Cutting Edge or Cutting Corners? Innovative Care

Chapter

Abstract

Despite an ever-increasing body of scientific evidence, clinical situations often arise for which there are no well-accepted therapies. A physician may respond, for example, by using a drug “off-label” (i.e. to treat a condition for which it is not FDA-approved) or develop a new procedure with the aim of providing more benefit to the patient with less harm than standard approaches permit [1]. An innovative therapy is an unproven treatment approach used in clinical practice for the benefit of a patient. It contrasts with clinical research, which aims at testing the efficacy of an investigational therapy. However, since clinical practice and research often take place in the same facility under the supervision of the same physicians and the use of a novel therapy may both benefit a patient and generate new scientific knowledge, it is not always clear whether a novel therapy is innovative or investigational.

Keywords

Sentinel Lymph Node Biopsy Merkel Cell Carcinoma Wide Local Excision National Comprehensive Cancer Network Guideline Innovative Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jonsen A, Siegler M, Winslade W. Clinical ethics: a practical approach to ethical decisions in clinical medicine. 6th ed. New York: McGraw-Hill; 2006.Google Scholar
  2. 2.
    The Belmont Report: ethical principles and guidelines for the protection of human subjects of research(os) 78-0012. DHEW.Google Scholar
  3. 3.
    Annas GJ. Cancer and the constitution–choice at life’s end. N Engl J Med. 2007;357(4):408–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127(9):2100–3.PubMedCrossRefGoogle Scholar
  5. 5.
    Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007;110(1):1–12.PubMedCrossRefGoogle Scholar
  6. 6.
    NCCN clinical practice guidelines in oncology: merkel cell carcinoma. In: Network NCC, ed. 2010.Google Scholar
  7. 7.
    Busse PM, Clark JR, Muse VV, Liu V. Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma. N Engl J Med. 2008;358(25):2717–23.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.Department of Emergency Medicine, Boston Medical CenterBoston University School of MedicineBostonUSA
  2. 2.Fox Chase Cancer CenterPhiladelphiaUSA

Personalised recommendations